Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

G. G. Song; Y. H. Lee

doi:10.1007/s00393-019-0601-3

Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Zeitschrift für Rheumatologie ◽

10.1007/s00393-019-0601-3 ◽

2019 ◽

Vol 79 (1) ◽

pp. 103-111

Author(s):

G. G. Song ◽

Y. H. Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Clinical Rheumatology ◽

10.1007/s10067-018-4002-9 ◽

2018 ◽

Vol 37 (5) ◽

pp. 1199-1205

Author(s):

Sang-Cheol Bae ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

THU0213 Comparative efficacy and safety of baricitinib 2 MG and 4 MG in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials

10.1136/annrheumdis-2017-eular.1245 ◽

2017 ◽

Author(s):

YH Lee ◽

YH Seo ◽

GG Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Clinical Drug Investigation ◽

10.1007/s40261-019-00863-9 ◽

2019 ◽

Vol 40 (1) ◽

pp. 65-72 ◽

Cited By ~ 1

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative efficacy and safety of 100 mg and 200 mg filgotinib administered to patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp203635 ◽

2020 ◽

Vol 58 (06) ◽

pp. 293-298

Author(s):

Gwan Gyu Song ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Rheumatology International ◽

10.1007/s00296-015-3291-4 ◽

2015 ◽

Vol 35 (12) ◽

pp. 1965-1974 ◽

Cited By ~ 12

Author(s):

Young Ho Lee ◽

Sang-Cheol Bae ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Zeitschrift für Rheumatologie ◽

10.1007/s00393-019-00733-x ◽

2019 ◽

Vol 79 (6) ◽

pp. 590-603

Author(s):

Y. H. Lee ◽

G. G. Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Zeitschrift für Rheumatologie ◽

10.1007/s00393-018-0531-5 ◽

2018 ◽

Vol 78 (6) ◽

pp. 559-567 ◽

Cited By ~ 6

Author(s):

S.-C. Bae ◽

Y. H. Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

FRI0158 COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND UPADACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

10.1136/annrheumdis-2019-eular.820 ◽

2019 ◽

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta‐analysis of randomized controlled trials

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.13854 ◽

2020 ◽

Vol 23 (7) ◽

pp. 868-875

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp204017 ◽

2021 ◽

Author(s):

Yoon-Kyoung Sung ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

THU0213 Comparative efficacy and safety of baricitinib 2 MG and 4 MG in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials

Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Comparative efficacy and safety of 100 mg and 200 mg filgotinib administered to patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

FRI0158 COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND UPADACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta‐analysis of randomized controlled trials

Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials